A complement C4 (also known as a complement component 4, or simply C4) is a test to measure the level of C4 proteins you have in your blood. These proteins play a role in how your immune system ...

US politicians hear option of not selling Australia nuclear submarines Family suspect twist in likely death of missing boy Gus Elon Musk warns a new social network where AI agents talk to one another ...

Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...

YOU HEAR Frank Nazar before you see him. There's a rich laugh. Some quick chirps. His Chicago Blackhawks teammates turning heads in his direction as Nazar comes into view. Smile beaming. Happy to be ...

Complement 3 glomerulopathy (C3G) is considered a very rare disease. With C3G, patients have issues with their immune system that cause kidney damage and symptoms such as swelling and changes in urine ...

Is it a sign of a good healthcare system when millions of people turn to a hallucinating robot for help? Reading time 2 minutes OpenAI just released a report about healthcare drawn from anonymized ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

Also called C3G, this rare kidney disease often affects children and young adults, but it can happen at any age. It has a major impact on a person’s health and life. C3G has two forms: dense deposit ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

The Pac-12 has undergone as bigger shuffle than any other as the conference-realignment era of college athletics has shaken up countless programs around the country. Oregon State and Washington State ...

Vanguard Extended Market ETF VXF tracks a total market index that excludes S&P 500 stocks. It’s a misfit in the mid-cap blend category, but it pairs well with a fund that tracks the S&P 500 index to ...